Quanterix Corporation Deferred Revenue Recognized
Quanterix Corporation (QTRX) reported Deferred Revenue Recognized of $4.70 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Income Statement › Other Income
us-gaap:ContractWithCustomerLiabilityRevenueRecognized · last filed 2026-08-10
- Quanterix Corporation contract with customer, liability, revenue recognized for the quarter ending 2026-06-30 was $4.70M, a 51.61% increase year-over-year.
- Quanterix Corporation contract with customer, liability, revenue recognized for the quarter ending 2026-03-31 was $3.50M, a 40.00% increase year-over-year.
- Quanterix Corporation contract with customer, liability, revenue recognized for the quarter ending 2025-06-30 was $3.10M, a 40.91% increase year-over-year.
- Quanterix Corporation contract with customer, liability, revenue recognized for the quarter ending 2025-03-31 was $2.50M.
- Quanterix Corporation contract with customer, liability, revenue recognized for fiscal 2025 was $6.50M, a 17.72% decline from fiscal 2024.
- Quanterix Corporation contract with customer, liability, revenue recognized for fiscal 2024 was $7.90M.
- Quanterix Corporation contract with customer, liability, revenue recognized for fiscal 2021 was -$6.63M.
- Quanterix Corporation contract with customer, liability, revenue recognized for fiscal 2020 was -$6.12M.
| Period end | Contract with Customer, Liability, Revenue Recognized 3 month | Contract with Customer, Liability, Revenue Recognized 6 month | Contract with Customer, Liability, Revenue Recognized 9 month | Contract with Customer, Liability, Revenue Recognized 12 month |
|---|---|---|---|---|
| 2026-06-30 | $4.70M 10-Q · filed 2026-08-10 | $8.20M 10-Q · filed 2026-08-10 | ||
| 2026-03-31 | $3.50M 10-Q · filed 2026-05-06 | |||
| 2025-12-31 | $6.50M 10-K · filed 2026-03-02 | |||
| 2025-09-30 | $8.30M 10-Q · filed 2025-11-10 | |||
| 2025-06-30 | $3.10M 10-Q · filed 2026-08-10 | $5.60M 10-Q · filed 2026-08-10 | ||
| 2025-03-31 | $2.50M 10-Q · filed 2026-05-06 | |||
| 2024-12-31 | $7.90M 10-K · filed 2026-03-02 | |||
| 2024-09-30 | $6.50M 10-Q · filed 2025-11-10 | |||
| 2024-06-30 | $2.20M 10-Q · filed 2025-08-07 | $4.90M 10-Q · filed 2025-08-07 | ||
| 2023-09-30 | $6.40M 10-Q · filed 2024-12-26 | |||
| 2023-06-30 | $4.90M 10-Q/A · filed 2024-12-26 | |||
| 2022-06-30 | -$4.17M 10-Q · filed 2022-08-08 | |||
| 2022-03-31 | -$2.04M 10-Q · filed 2022-05-10 | |||
| 2021-12-31 | -$6.63M 10-K · filed 2022-03-01 | |||
| 2021-09-30 | -$4.81M 10-Q · filed 2021-11-04 | |||
| 2021-06-30 | -$3.08M 10-Q · filed 2021-08-05 | |||
| 2021-03-31 | -$1.47M 10-Q · filed 2021-05-06 | |||
| 2020-12-31 | -$6.12M 10-K · filed 2021-03-05 | |||
| 2020-09-30 | -$2.39M 10-Q · filed 2020-11-06 | |||
| 2020-06-30 | -$2.35M 10-Q · filed 2020-08-04 | |||
| 2020-03-31 | -$1.18M 10-Q · filed 2020-05-07 | |||
| 2019-12-31 | -$4.63M 10-K · filed 2020-03-13 | |||
| 2019-09-30 | -$3.25M 10-Q · filed 2019-11-08 | |||
| 2019-06-30 | -$2.10M 10-Q · filed 2019-08-06 | |||
| 2019-03-31 | -$960.00K 10-Q · filed 2019-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |